Echocardiographic Changes in Patients with ESRD on Maintenance Hemodialysis-A Single Centre Study
作者： Shivendra Singh , PK Doley , P Pragya , M Sivasankar , VP Singh
DOI: 10.4172/2329-9517.1000165
关键词:
摘要: Objective: To evaluate and analyze the echocardiographic changes in end stage renal disease patients on maintenance hemodialysis. Material methods: End (ESRD) hemodialysis for at least 3 months were included study. We performed M-mode echocardiography 35 ESRD during interdialytic period usually after 18 hours, without obvious clinical evidence of coronary artery disease, valvular heart congenital pericardial effusion. Results: Echocardiography revealed LV dilation diastolic dysfunction (51.2%), left ventricular hypertrophy (LVH) 17 (48%), systolic effusion 10 (28.57%) 6 (17.14%) respectively. RWMA was present 8.5% calcification not seen our patient group. In sub-group with Hb<10 gm%, LVH 71.42% (15) vs 14.28% (2) group Hb ≥ gm% (p=0.002). Hypertensive population also had higher prevalence (51.85%)] absent normotensive group. Conclusion: most common findings. There statistically significant correlation between anemia presence positive hypertension LVH.
hilarispublisher.com参考文章(18)
Terho Lehtimäki, Sanna Kilpinen, Yrjö Leskinen, Juhani Airaksinen, Tuomas Paana, Kaj Groundstroem, Heikki Saha, Heini Huhtala, Valvular calcification and its relationship to atherosclerosis in chronic kidney disease. Journal of Heart Valve Disease. ,vol. 18, pp. 429- 438 ,(2009)
Gaetano Santulli, Bruno Trimarco, Guido Iaccarino, G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms. Annual Review of Physiology. ,vol. 20, pp. 5- 12 ,(2013) , 10.1007/S40292-013-0001-8
J. V. McMurray, T. A. McDonagh, A. P. Davie, J. G. F. Cleland, C. M. Francis, C. Morrison, Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure European Heart Journal. ,vol. 19, pp. 842- 846 ,(1998) , 10.1093/EURHEARTJ/19.6.842
Patrick S. Parfrey, John D. Harnett, Gloria M. Kent, Robert N. Foley, Cardiac function and hematocrit level American Journal of Kidney Diseases. ,vol. 25, ,(1995) , 10.1016/0272-6386(95)90673-8
Robert N. Foley, Patrick S. Parfrey, John D. Harnett, Gloria M. Kent, Christopher J. Martin, David C. Murray, Paul E. Barre, Clinical and echocardiographic disease in patients starting end-stage renal disease therapy Kidney International. ,vol. 47, pp. 186- 192 ,(1995) , 10.1038/KI.1995.22
P. S. Parfrey, R. N. Foley, J. D. Harnett, G. M. Kent, D. C. Murray, P. E. Barre, Outcome and risk factors for left ventricular disorders in chronic uraemia Nephrology Dialysis Transplantation. ,vol. 11, pp. 1277- 1285 ,(1996) , 10.1093/NDT/11.7.1277
Robert N. Foley, Patrick S. Parfrey, John D. Harnett, Gloria M. Kent, David C. Murray, Paul E. Barre, The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease☆ American Journal of Kidney Diseases. ,vol. 28, pp. 53- 61 ,(1996) , 10.1016/S0272-6386(96)90130-4
Lawrence Y. Agodoa, Paul W. Eggers, Renal replacement therapy in the United States: Data from the United States renal data system American Journal of Kidney Diseases. ,vol. 25, pp. 119- 133 ,(1995) , 10.1016/0272-6386(95)90638-X
Roberto Pecoits-Filho, Silvio H. Barberato, Echocardiography in chronic kidney disease: diagnostic and prognostic implications. Nephron Clinical Practice. ,vol. 114, ,(2010) , 10.1159/000276575
Adeera Levin, Joel Singer, Christopher R. Thompson, Heather Ross, Mary Lewis, Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention☆☆☆ American Journal of Kidney Diseases. ,vol. 27, pp. 347- 354 ,(1996) , 10.1016/S0272-6386(96)90357-1